The influence of propranolol, INPEA, iproveratril and some 1-naphthylethylamine derivatives on the myocardial phosphorylase activity.
D000227:Adenine Nucleotides; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D004336:Drug Antagonism; D004790:Enzyme Induction; D005021:Ethylamines / Q000494:pharmacology*; D005947:Glucose; D005964:Glucosyltransferases; D006003:Glycogen; D006321:Heart / Q000187:drug effects; D006600:Hexosephosphates; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008112:Liver Glycogen; D008297:Male; D008433:Mathematics; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000201:enzymology*; D009281:Naphthalenes / Q000494:pharmacology*; D009570:Nitriles / Q000494:pharmacology*; D009578:Nitrobenzenes / Q000494:pharmacology; D010477:Perfusion; D010627:Phenethylamines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D013237:Stereoisomerism; D013268:Stimulation, Chemical; D013565:Sympatholytics / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D000227:Adenine Nucleotides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000889:Anti-Arrhythmia Agents; D005021:Ethylamines; D006600:Hexosephosphates; D008112:Liver Glycogen; D009281:Naphthalenes; D009570:Nitriles; D009578:Nitrobenzenes; D010627:Phenethylamines; D013565:Sympatholytics; D014665:Vasodilator Agents; D006003:Glycogen; D011433:Propranolol; D014700:Verapamil; D005964:Glucosyltransferases; D005947:Glucose; D007545:Isoproterenol